DermTech, Inc. DMTKQ
0.00
0.00
NaN
as of 13 Aug
- Market cap
- $3.3M
- P/E
- 0.0×
Follow DMTKQ
Growth Flags
show if company had growth for consecutive years
| Mar '17 | Dec '17 | Mar '18 | Dec '18 | Mar '19 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | 0.00 | — | 25.82 | 93.60 | 38.55 | 3.77 | 3.54 |
P/FCF ratio |
— | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | 9.20 | — | (14.29) | (81.64) | (20.12) | (2.58) | (4.26) |
P/B ratio |
— | — | — | 0.00 | — | 6.96 | 8.91 | 1.99 | 0.41 | 0.95 |
Price to Tangible BV |
— | — | — | 0.00 | — | 6.96 | 8.91 | 1.99 | 0.41 | 0.95 |
EV/Sales |
— | — | — | 0.00 | — | 21.40 | 83.08 | 19.54 | (4.92) | (0.11) |
EV/EBITDA |
— | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.63 | 0.02 |
EV/Operating CF |
— | — | — | (60.35) | — | (4.05) | (17.04) | (3.72) | 0.75 | 0.02 |
EV/FCF |
— | — | — | (60.35) | — | (4.00) | (16.02) | (3.57) | 0.72 | 0.02 |
Quick Ratio |
0.14 | 0.00 | 10.74 | 0.51 | 0.02 | 2.81 | 12.03 | 18.81 | 8.34 | 4.35 |
Current Ratio |
0.14 | 6.00 | 12.97 | 0.51 | 0.05 | 3.00 | 12.33 | 19.11 | 8.70 | 4.59 |
Net Debt/EBITDA |
250.00 | — | 1.47 | 0.56 | 0.02 | 0.99 | 1.78 | 3.03 | 1.11 | 0.57 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 9.11% | 0.00% | 0.00% | 2.69% | 0.11% | 0.03% | 0.03% |
Debt/Equity |
0.00 | — | 0.00 | (0.10) | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.22 | 0.13 | 0.07 | 0.06 | 0.09 |
Operating CF/Net income |
(22.00) | (0.85) | (0.44) | 0.76 | (0.47) | 0.88 | 0.79 | 0.79 | 0.82 | 0.76 |
Capex/Depreciation |
— | 0.00 | — | (0.01) | — | (0.10) | (3.94) | (0.89) | (0.68) | (0.17) |
Interest Coverage |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (1.03%) | 0.00% | 34.10% | 5,636.06% | (532.11%) | (230.20%) | (98.15%) | (53.74%) | (64.46%) | (106.46%) | |
| (0.05%) | 1.17% | 0.58% | (13.12%) | 10.43% | (131.35%) | (82.91%) | (49.25%) | (51.81%) | (62.28%) | |
ROIC |
0.00% | — | (4.21%) | 0.00% | (24.88%) | 0.00% | 0.00% | (1,040.52%) | (1,182.97%) | (4,806.29%) |
Return on Tangible Assets |
0.07% | 1,712.80% | 170.77% | 204.62% | (63.96%) | (162.27%) | (56.83%) | (34.79%) | (92.04%) | (189.31%) |
Average Days of Receivables |
— | — | — | 86.69 | — | 73.78 | 91.79 | 118.61 | 104.89 | 61.66 |
Research and Development Expense of Revenue |
— | 0.00% | — | 84.11% | — | 74.23% | 89.94% | 137.36% | 165.67% | 99.63% |
Selling, General and Administrative Expense of Revenue |
— | — | — | 258.85% | — | 450.89% | 508.07% | 527.21% | 652.71% | 580.39% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | — | 37.35% | — | 38.76% | 84.44% | 112.15% | 130.42% | 121.37% |
Graham Net Nets |
— | — | — | (0.11) | — | 0.13 | 0.11 | 0.47 | 1.21 | (0.06) |
Graham Number |
— | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | (0.64%) | — | (23.26%) | (6.44%) | (17.09%) | (213.74%) | (189.16%) |
Free Cash Flow Yield |
— | — | — | (1.52%) | — | (20.72%) | (5.54%) | (14.20%) | (180.29%) | (143.73%) |
Revenue per Share |
0.00 | — | 0.00 | 0.55 | 0.00 | 0.48 | 0.35 | 0.41 | 0.48 | 0.47 |
Operating CF per Share |
0.00 | 0.00 | (0.08) | (1.72) | (0.09) | (2.54) | (1.69) | (2.15) | (3.17) | (2.36) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.03) | (0.11) | (0.09) | (0.11) | (0.03) |
Free Cash Flow per Share |
0.00 | 0.00 | (0.08) | (1.73) | (0.09) | (2.57) | (1.80) | (2.24) | (3.28) | (2.39) |
Cash per Share |
0.01 | — | 0.10 | 1.08 | 0.01 | 2.19 | 3.76 | 7.80 | 4.20 | 1.71 |
Shareholders Equity per Share |
0.01 | — | 1.06 | (1.21) | 0.97 | 1.78 | 3.64 | 7.95 | 4.41 | 1.75 |
Interest Debt per Share |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.01 | — | 1.06 | (1.21) | 0.97 | 1.78 | 3.64 | 7.95 | 4.41 | 1.75 |
Free Cash Flow |
0.00 | (0.73) | (0.37) | (7.62) | (0.44) | (18.00) | (30.52) | (64.83) | (98.56) | (77.88) |
Working Capital |
(0.15) | 0.05 | 0.50 | (5.10) | (1.48) | 11.43 | 61.46 | 220.64 | 120.40 | 48.31 |
Capital Expenditures |
— | 0.00 | — | (0.01) | — | (0.21) | (1.83) | (2.72) | (3.30) | (0.90) |
Net Current Asset Value |
(0.15) | (4.98) | (141.35) | (5.62) | (7.36) | 11.43 | 58.94 | 214.21 | 66.32 | (3.00) |
EV/EBIT |
— | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.60 | 0.02 |
Capex to Sales |
— | 0.00 | — | 0.00 | — | 0.06 | 0.31 | 0.23 | 0.23 | 0.06 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | (409.66%) | 0.00% | (598.39%) | (619.83%) | (661.72%) | (803.71%) | (659.57%) |
Price to Operating Income |
— | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
— | 0.00 | — | 4.83 | — | 2.12 | 0.17 | 0.67 | 0.76 | 1.07 |
Cash ROIC |
4.66% | 0.00% | (6.85%) | 9,093.02% | (8.84%) | (67.36%) | (24.64%) | (14.64%) | (39.31%) | (72.49%) |
Accounts Receivable Turnover |
— | — | — | 3.88 | — | 5.34 | 5.45 | 4.44 | 3.62 | 4.53 |
Accounts Payable Turnover |
0.01 | — | 17.30 | 16.58 | 2.19 | 2.11 | 3.76 | 4.74 | 5.24 | 7.70 |
Inventory Turnover |
0.00 | — | 0.00 | 70.05 | 0.00 | 88.11 | 86.06 | 36.18 | 12.40 | 10.88 |
Average Days of Payables |
16,425.00 | — | 36.83 | 39.74 | 280.89 | 177.75 | 95.99 | 99.51 | 63.65 | 36.06 |
Days of Inventory on Hand |
0.00 | — | 0.00 | 5.56 | 0.00 | 3.87 | 6.35 | 16.58 | 46.23 | 24.40 |
Average Receivables |
— | — | — | 0.63 | — | 0.63 | 1.08 | 2.66 | 4.01 | 3.38 |
Average Payables |
0.02 | — | 0.02 | 0.16 | 0.90 | 1.57 | 1.59 | 2.23 | 2.65 | 1.95 |
Average Inventory |
— | — | — | 0.04 | — | 0.04 | 0.07 | 0.29 | 1.12 | 1.38 |
Average Assets |
0.19 | 73.06 | 146.41 | 76.28 | 9.05 | 15.33 | 44.00 | 159.04 | 225.19 | 162.00 |
Average Common Equity |
0.01 | — | 2.51 | (0.18) | (0.18) | 8.74 | 37.16 | 145.77 | 181.03 | 94.76 |
Columns are period end dates